Allurion Technologies Inc. (ALUR)
NYSE: ALUR · Real-Time Price · USD
5.35
-0.37 (-6.47%)
Jan 30, 2025, 4:00 PM EST - Market closed
Allurion Technologies Employees
As of December 31, 2023, Allurion Technologies had 504 total employees, including 501 full-time and 3 part-time employees. The number of employees increased by 248 or 96.88% compared to the previous year.
Employees
504
Change (1Y)
248
Growth (1Y)
96.88%
Revenue / Employee
$68,956
Profits / Employee
-$49,127
Market Cap
18.37M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 504 | 248 | 96.88% |
| Dec 31, 2022 | 256 | 29 | 12.78% |
| Dec 31, 2021 | 227 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ALUR News
- 6 days ago - Allurion Technologies Shares Are Up Today: What's Going On? - Benzinga
- 6 days ago - Allurion Stock Triples on Plan to Test Gastric Balloon With Obesity Drugs - Investopedia
- 6 days ago - Allurion to Raise Approximately $7.4 Million of Gross Proceeds in Offering Priced At-the-Market - Business Wire
- 7 days ago - Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program - Business Wire
- 9 days ago - Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity - Business Wire
- 16 days ago - Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024 - Business Wire
- 22 days ago - Allurion Announces Positive Topline Results From AUDACITY Trial - Business Wire
- 5 weeks ago - Allurion Technologies, Inc. Announces Reverse Stock Split - Business Wire